CHICAGO, June 27, 2016 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) has implemented an aggressive strategy to drive innovation and client success through the EPSi solution, its flagship budgeting, cost accounting and financial decision support platform. The company will accelerate development with new executive leadership and a future-focused roadmap to meet rapidly changing market needs.
“Having been a chief financial officer myself, I understand the strategic importance of tools like EPSi for financial planning, scenario modeling and critical decision support in a time of rapid industry transition,” Allscripts President Rick Poulton said. “We’re executing our plan by making a significant investment in EPSi to further advance its place as a market-leading solution.”
As of June 27, EPSi founder Tim Rutledge and former management executives Ralph Keiser and John Gragg will join Allscripts to lead the efforts in executing the new solution strategy. Ralph Keiser will be the CEO of the EPSi business unit, with John Gragg functioning as COO and Tim Rutledge as Chief Product Architect. Chuck Manternach, who has been with Allscripts since 2005, will also take on a greater leadership role in the organization as Associate General Manager for EPSi. With extensive industry experience and knowledge, this team will develop a new product roadmap that will keep EPSi users at the forefront of healthcare evolution.
In conjunction with the investment in EPSi, Allscripts has acquired RealCost.io, Inc., a next-generation decision support and analytics firm founded by Keiser, Rutledge and Gragg.
“We are excited to join Allscripts and lead the EPSi business into its next phase of growth and innovation,” said Keiser. “Our focus will be to improve the current client experience with our products and services and to expand the capabilities of our market-leading platform that powers some of the largest healthcare systems in the market. I look forward to working with the EPSi team to create and launch innovative solutions that help our clients as they transition from volume to value and deliver cost saving operational efficiencies.”
“These industry leaders had the vision to create EPSi, and now they will use their expertise to advance the solution to the next level,” Poulton said. “We remain 100% committed to our long-term partnership with clients and delivering the best EPSi solutions.”
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2016 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.